Skip to content
DrPlus
Doctor-Led · Collagen Biostimulators

DrPlus Skin Education · Singapore

Collagen Biostimulators Singapore: Lenisna & Sculptra

Lenisna and Sculptra both stimulate collagen, but their formulations and planning differ. This guide explains where they may fit and where they do not.

9 min readUpdated 20 Sep 2026
Clinical illustration explaining gradual collagen stimulation with Lenisna and Sculptra
Medically reviewed by Dr Kenneth Lee, Medical DirectorLast reviewed 20 Sep 2026
Considering treatment? See doctor-led collagen stimulation options in Singapore.

What a collagen biostimulator does

A collagen biostimulator places biodegradable particles into selected tissue planes to prompt a controlled healing response and new collagen formation. Unlike conventional hyaluronic-acid filler, the intended change develops gradually as the tissue responds.

Biostimulators cannot stop ageing, tighten every degree of laxity or reproduce surgery. They may be considered for selected patients seeking gradual support to skin quality or volume distribution after a doctor assesses anatomy and expectations.

Lenisna versus Sculptra: the practical differences

Sculptra uses PLLA microparticles and is generally planned as a gradual collagen-stimulation course. Lenisna uses PDLLA particles combined with hyaluronic acid, giving it a different formulation and handling profile. Neither should be selected from a brand comparison alone.

Preparation, dilution, placement depth and treatment zones matter. Availability and regulatory status should be confirmed by the treating clinic for the specific product and indication rather than inferred from overseas advertising.

— Comparison

Lenisna and Sculptra at a glance

Core material

Sculptra
PDLLA with HA
PLLA

Treatment logic

Sculptra
Immediate carrier effect plus gradual stimulation
Gradual collagen stimulation

Planning

Sculptra
Area, depth and amount are individualised
Course and amount are individualised

Assessment

Sculptra
Doctor-led suitability review
Doctor-led suitability review

Who may — and may not — be suitable

A possible candidate has a concern that matches gradual collagen support, realistic expectations and no contraindication identified at assessment. The doctor considers facial structure, skin thickness, prior injectables, scarring tendency, medications and the ability to attend follow-up.

Treatment may be deferred during pregnancy or breastfeeding, active infection or inflammation, and in people with relevant immune, bleeding or healing concerns. Significant loose skin, a need for precise immediate shaping, or expectations equivalent to surgery may point to another pathway.

Treatment course, aftercare and risks

The number of sessions and review interval are individual. Bruising, swelling, tenderness and temporary unevenness can occur. Patients receive product-specific aftercare; instructions should not be copied from another brand or social-media protocol.

Less common but important complications include persistent lumps or nodules, infection, inflammatory reactions and vascular compromise. Seek urgent review for increasing pain, blanching or dusky skin, visual symptoms, fever, or rapidly worsening swelling.

How a Singapore consultation should decide

A useful consultation starts with the concern and anatomy, then considers whether a biostimulator, another injectable, an energy-based treatment or no procedure is appropriate. Ask which product is proposed, why it fits, its regulatory status, alternatives, expected review points and complication plan.

At DrPlus Singapore, treatment is recommended only after individual assessment. Outcomes vary, and a written plan should give you time to consider the information without pressure.

— Frequently asked

Common questions

It is an injectable designed to encourage the body to produce collagen gradually. It differs from conventional filler because the intended effect develops through a tissue response rather than only immediate gel volume.

No. Lenisna combines PDLLA particles with hyaluronic acid, while Sculptra uses PLLA. Their preparation and planning differ, and suitability is assessed individually.

Early swelling or carrier volume is not the final effect. Collagen-related changes develop over weeks to months and vary by product, area and individual response.

They are injectable implants, but their primary treatment logic is collagen stimulation. Some formulations also contain a carrier that gives temporary early volume. Your doctor should explain the proposed job clearly.

No. It may support tissue quality in selected cases but cannot remove substantial excess skin or reproduce surgical repositioning. Significant laxity may warrant a surgical opinion.

— Related treatments

Each page goes deeper into mechanism, suitability and recovery — your final plan is confirmed at consultation.

— Continue reading